Researchers in the Perelman School of Medicine at the University of Pennsylvania reports a genome-wide association study that identified 182 genes likely responsible for kidney function and 88 genes for hypertension. Additionally, the research team has mapped the key cell types and mechanisms that are linked to disease. The findings were published today in Nature.
“This is a key roadmap for understanding the mechanisms of chronic kidney disease,” lead researcher Katalin Susztak said. “The existing maps have indicated regions in the genome for kidney disease heritability, like an initial treasure map, but, until now, we did not know where the treasure chest was located or how it looked. Our goal was to find the exact location of the treasure and to open up the box to see what was inside.”
One key challenge in translating genetic maps to specific genes is that most of the genetic variants that can cause kidney disease to alter how the genes are regulated. To overcome this challenge, researchers collected 659 human kidney samples. After manually dissecting each tissue sample, they analyzed the expression of each gene and the genetic variation.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
The team next generated gene expression and regulation data for each human kidney cell type using a newly-developed single-cell sequencing method. This enabled the researchers to identify the key cell types where the genetic variant induces a faulty expression of genes. Their results identified nearly 200 genes for kidney function, as well as nearly 100 genes for hypertension. Finally, the researchers clarified the mechanisms behind several existing kidney disease drugs—including angiotensin-converting enzyme inhibitors and angiotensin receptor blockers — showing that they matched with the genes implicated in the disease.